SCM
NAGE

Sterling Capital Management’s Niagen Bioscience NAGE Stock Holding History

Sterling Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$648 Sell
203
-136
-40% -$552 ﹤0.01% 3200
2026
Q1 		$1.5K Hold
339
– – ﹤0.01% 3038
2025
Q4 		$2.16K Buy
339
+213
+169% +$1.48K ﹤0.01% 3058
2025
Q3 		$1.18K Hold
126
– – ﹤0.01% 3059
2025
Q2 		$1.82K Buy
126
+76
+152% +$750 ﹤0.01% 2943
2025
Q1 		$345 Hold
50
– – ﹤0.01% 3018
2024
Q4 		$265 Hold
50
– – ﹤0.01% 3097
2024
Q3 		$183 Buy
+50
New +$157 ﹤0.01% 3125

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sterling Capital Management's NAGE Position: Q2 2026 in Review

Sterling Capital Management reduced its Niagen Bioscience (NAGE) stake by 40% in Q2 2026, selling an estimated $552 and leaving 203 shares worth $648. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Sterling Capital Management first reported a position in NAGE in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.16K in Q4 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Sterling Capital Management held 203 shares of Niagen Bioscience worth $648 as of Q2 2026.
  • Sterling Capital Management sold 136 Niagen Bioscience shares in Q2 2026, an estimated $552.
  • Niagen Bioscience made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3200 holding.
  • Sterling Capital Management first reported a position in Niagen Bioscience in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Niagen Bioscience position peaked at $2.16K in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.